Asensus Surgical - ASXC Company Value to Revenue Ratio

Public company logo of TransEnterix (ASXC)

Chip supply optimization supports high margins for Asensus Surgical, Inc. (ASXC). The EV/Sales trend clearly demonstrates position accumulation, with this metric currently standing at . Revenues are based on the sale of Senhance systems to minimally invasive surgery centers. However, weak pricing power forces the company to offer significant discounts to compete with market leaders.

ASXC Asensus Surgical: EV/Sales Multiple in the range 07/04/2022 - 11/20/2026

ASXC (asensus.com): analytical breakdowns and indicator data

- price and consensus price forecast:
Fundamental valuation:Asensus Surgical Inc ASXC
Mass-produced product of Asensus Surgical, Inc.

By developing high-precision robotic systems for minimally invasive surgery, Asensus Surgical, Inc. (ASXC) is pursuing global expansion and risk diversification. The EV/Sales metric reflects the enterprise value inclusive of net debt relative to sales volumes, allowing investors to assess the resilience of the capitalization against macroeconomic shocks during a prolonged sideways trend and determine the asset's potential as a defensive tool.

Competitor analysis for Asensus Surgical, Inc.

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue CONMED Corporation CNMD|EV/Sales Multiple PLSE (pulsebiosciences.com)|EV/Sales Multiple InMode Ltd INMD|PMI: Company Value to Revenue|SRDX: Enterprise Value-to-Revenue Ratio|SENS (Senseonics Corp) - Company Value to Revenue|NeuroPace, Inc. - Business Value to Revenue|TCMD (Tactile Systems Technology, Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SANUWAVE Health SNWV|EV/Sales Multiple OM|Electromed Inc (ELMD) - Enterprise Value-to-Sales Ratio|LENSAR Inc - Company Value to Revenue|EV/Sales Multiple AVITA Medical, Inc. RCEL|Profound Medical Corp - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Baird Medical BDMD|EDAP TMS (EDAP) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume APYX (Bovie Medical)|Enterprise Value-to-Revenue Ratio icecure-medical.com|Company Value to Revenue Pulmonx Corporation (LUNG)|EV/Sales Multiple TELA|CTSO - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Sensus Healthcare, Inc. SRTS|ZYXI: Company Value to Revenue Ratio|ECOR: Company Value to Revenue|Vicarious Surgical Inc - Enterprise Value-to-Revenue Coefficient|IINN: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SeaStar Medical (ICU)|Enterprise Value-to-Revenue Ratio iridex.com|Company Value to Revenue Ratio INBS (Intelligent Bio Solutions Inc.)|Company Value to Revenue XAIR (Beyond Air, Inc.)|PFSA - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple SSKN (STRATA Skin Sciences Inc.)|GCTK - Company Value to Revenue|NAOV: Company Value to Revenue|Total Company Value-to-Revenue Ratio Venus Concept Inc. VERO|Nuwellis, Inc. (NUWE) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple aethlonmedical.com (AEMD)|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)